US Biomax, Inc.

PR803

Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases/80 cores, replacing PR801, replaced by PR803a

Microarray Panel:Prostate carcinoma tissue microarray, single core array, 70 cases of prostate in various stages plus 7 cases of normal tissue and 3 matched normal tissue
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Proliferating Cell Nuclear Antigen (PCNA) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Gleason Grade Gleason Score Image Type †
A1 1 M 66 Prostate Transitional cell carcinoma 2 Malignant
A2 2 M 60 Prostate Adenocarcinoma 1 1 3 Malignant
A3 3 M 64 Prostate Adenocarcinoma 2 1 3 Malignant
A4 4 M 82 Prostate Adenocarcinoma 2 2 5 Malignant
A5 5 M 75 Prostate Adenocarcinoma 1 1 3 Malignant
A6 6 M 75 Prostate Adenocarcinoma 2 2 5 Malignant
A7 7 M 72 Prostate Adenocarcinoma 3 5 10 Malignant
A8 8 M 63 Prostate Adenocarcinoma 2 3 7 Malignant
A9 9 M 85 Prostate Adenocarcinoma 2 2 5 Malignant
A10 10 M 66 Prostate Adenocarcinoma 1 1 3 Malignant
B1 11 M 75 Prostate Adenocarcinoma 2 3 7 Malignant
B2 12 M 62 Prostate Adenocarcinoma 2 4 9 Malignant
B3 13 M 67 Prostate Adenocarcinoma 2 1 3 Malignant
B4 14 M 72 Prostate Adenocarcinoma 1 1 3 Malignant
B5 15 M 64 Prostate Adenocarcinoma 3 4 9 Malignant
B6 16 M 64 Prostate Adenocarcinoma 3 4 9 Malignant
B7 17 M 70 Prostate Adenocarcinoma 2 4 9 Malignant
B8 18 M 73 Prostate Adenocarcinoma 2 3 7 Malignant
B9 19 M 69 Prostate Adenocarcinoma 2 3 7 Malignant
B10 20 M 76 Prostate Adenocarcinoma 3 1 3 Malignant
C1 21 M 72 Prostate Adenocarcinoma 2 2 5 Malignant
C2 22 M 70 Prostate Sparse adenocarcinoma cells 2 1 3 Malignant
C3 23 M 70 Prostate Adenocarcinoma 2 3 7 Malignant
C4 24 M 65 Prostate Adenocarcinoma 2 3 7 Malignant
C5 25 M 75 Prostate Adenocarcinoma 3 2 5 Malignant
C6 26 M 78 Prostate Adenocarcinoma 3 5 10 Malignant
C7 27 M 77 Prostate Adenocarcinoma 3 4 9 Malignant
C8 28 M 63 Prostate Adenocarcinoma 3 3 7 Malignant
C9 29 M 64 Prostate Adenocarcinoma 2 2 5 Malignant
C10 30 M 73 Prostate Adenocarcinoma 3 3 7 Malignant
D1 31 M 55 Prostate Adenocarcinoma 2 5 10 Malignant
D2 32 M 82 Prostate Adenocarcinoma 4 3 7 Malignant
D3 33 M 62 Prostate Adenocarcinoma 1 3 7 Malignant
D4 34 M 55 Prostate Prostate tissue with squamous metaplasia 2 Malignant
D5 35 M 63 Prostate Adenocarcinoma 2 3 7 Malignant
D6 36 M 77 Prostate Adenocarcinoma 4 4 9 Malignant
D7 37 M 80 Prostate Adenocarcinoma 3 3 7 Malignant
D8 38 M 65 Prostate Adenocarcinoma 3 2 5 Malignant
D9 39 M 56 Prostate Adenocarcinoma 1 1 3 Malignant
D10 40 M 78 Prostate Adenocarcinoma 2 4 9 Malignant
E1 41 M 66 Prostate Adenocarcinoma 4 5 10 Malignant
E2 42 M 57 Prostate Adenocarcinoma 2 4 9 Malignant
E3 43 M 72 Prostate Cancer adjacent prostate tissue 2 Malignant
E4 44 M 75 Prostate Adenocarcinoma 4 5 10 Malignant
E5 45 M 87 Prostate Adenocarcinoma 4 5 10 Malignant
E6 46 M 81 Prostate Adenocarcinoma 3 4 9 Malignant
E7 47 M 60 Prostate Adenocarcinoma 4 5 10 Malignant
E8 48 M 76 Prostate Adenocarcinoma 3 3 7 Malignant
E9 49 M 51 Prostate Adenocarcinoma 3 3 7 Malignant
E10 50 M 64 Prostate Adenocarcinoma 2 3 7 Malignant
F1 51 M 65 Prostate Adenocarcinoma 3 1 3 Malignant
F2 52 M 83 Prostate Adenocarcinoma 3 2 5 Malignant
F3 53 M 82 Prostate Adenocarcinoma 4 5 10 Malignant
F4 54 M 69 Prostate Adenocarcinoma 1 2 5 Malignant
F5 55 M 73 Prostate Adenocarcinoma 3 4 9 Malignant
F6 56 M 60 Prostate Adenocarcinoma 3 4 9 Malignant
F7 57 M 72 Prostate Adenocarcinoma 4 5 10 Malignant
F8 58 M 69 Prostate Adenocarcinoma 3 4 9 Malignant
F9 59 M 69 Prostate Adenocarcinoma 2 5 10 Malignant
F10 60 M 73 Prostate Adenocarcinoma 2 4 9 Malignant
G1 61 M 64 Prostate Adenocarcinoma 4 4 9 Malignant
G2 62 M 72 Prostate Adenocarcinoma 4 4 9 Malignant
G3 63 M 81 Prostate Transitional cell carcinoma 2 Malignant
G4 64 M 69 Prostate Adenocarcinoma 2 4 9 Malignant
G5 65 M 57 Prostate Adenocarcinoma 4 5 10 Malignant
G6 66 M 40 Prostate Adenocarcinoma 3 4 9 Malignant
G7 67 M 74 Prostate Adenocarcinoma 2 4 9 Malignant
G8 68 M 70 Prostate Adenocarcinoma 1 3 7 Malignant
G9 69 M 56 Prostate Adenocarcinoma 2 3 7 Malignant
G10 70 M 73 Prostate Adenocarcinoma 2 2 5 Malignant
H1 71 M 62 Prostate Adenocarcinoma 2 5 10 Malignant
H2 72 M 72 Prostate Moderate malignant leiomyosarcoma Malignant
H3 73 M 67 Prostate Pleomorphic leiomyosarcoma Malignant
H4 74 M 77 Prostate Cancer adjacent normal prostate tissue NAT
H5 75 M 48 Prostate Cancer adjacent normal prostate tissue NAT
H6 76 M 69 Prostate Cancer adjacent normal prostate tissue NAT
H7 77 M 27 Prostate Cancer adjacent normal prostate tissue NAT
H8 78 M 25 Prostate Cancer adjacent normal prostate tissue NAT
H9 79 M 21 Prostate Cancer adjacent normal prostate tissue NAT
H10 80 M 63 Prostate Cancer adjacent normal prostate tissue NAT
Prostate adenocarcinoma grade: referring to Gleason's grading system

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.


Find overlapping cases with this tissue array: